Skip to main content

Zymeworks Inc.

ZYME
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001937653

No open-market purchases or sales by Zymeworks Inc. insiders were filed in the last 90 days; 202 institutions reported holding it in 13F filings for Q2 2026, worth $1.79B in total; no superinvestor holds it.

Superinvestors holding ZYME, Q2 2026

See all superinvestors

No superinvestor reported holding ZYME in Q2 2026.

Moves by quarter

Superinvestors that opened, added to, trimmed or sold out of ZYME each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.

  1. Q4 2021

    0 superinvestors holding at quarter end

    Sold out
    Lone Pine Capital